Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

OPGN

OpGen (OPGN)

OpGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OPGN
DateTimeSourceHeadlineSymbolCompany
11/19/20212:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
11/12/20214:29PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OPGNOpGen Inc
11/12/20216:36AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
11/11/20214:05PMGlobeNewswire Inc.OpGen Reports Third Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:OPGNOpGen Inc
11/04/20218:23AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
11/04/20217:31AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OPGNOpGen Inc
11/04/20217:30AMGlobeNewswire Inc.OpGen Appoints Albert Weber as Chief Financial OfficerNASDAQ:OPGNOpGen Inc
11/04/20217:30AMGlobeNewswire Inc.OpGen Announces Special Meeting of Stockholders to Vote on Proposed Increase to Number of Authorized Shares of Common StockNASDAQ:OPGNOpGen Inc
10/29/202110:08AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OPGNOpGen Inc
10/29/202110:06AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OPGNOpGen Inc
10/29/202110:04AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OPGNOpGen Inc
10/28/20217:30AMGlobeNewswire Inc.OpGen to Provide Business Update and Financial Results for the Third Quarter 2021 on November 11th at 4:30 p.m. Eastern TimeNASDAQ:OPGNOpGen Inc
10/21/20217:30AMGlobeNewswire Inc.OpGen Subsidiary Ares Genetics Launches AREScloudNASDAQ:OPGNOpGen Inc
10/19/20214:19PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:OPGNOpGen Inc
10/18/20214:30PMGlobeNewswire Inc.OpGen Announces Closing of $15 Million Registered Direct OfferingNASDAQ:OPGNOpGen Inc
10/15/20214:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
10/14/20218:00AMGlobeNewswire Inc.OpGen Announces $15 Million Registered Direct OfferingNASDAQ:OPGNOpGen Inc
10/04/20218:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
10/04/20217:30AMGlobeNewswire Inc.OpGen Provides Business Update and Announces Preliminary Unaudited Revenue and Cash Position for Third Quarter 2021NASDAQ:OPGNOpGen Inc
10/04/20217:30AMGlobeNewswire Inc.OpGen Receives FDA Clearance for Acuitas® AMR Gene PanelNASDAQ:OPGNOpGen Inc
09/30/20217:30AMGlobeNewswire Inc.OpGen Initiates Clinical Trial for Unyvero Urinary Tract Infection PanelNASDAQ:OPGNOpGen Inc
09/16/20216:06AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
09/15/20217:30AMGlobeNewswire Inc.OpGen Announces Data from Prospective Randomized Controlled Multicenter Clinical Study Using the Unyvero HPN Panel for Hospitalized Patients with Suspicion of PneumoniaNASDAQ:OPGNOpGen Inc
08/20/20216:03AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OPGNOpGen Inc
08/13/20215:32PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OPGNOpGen Inc
08/12/20215:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
08/12/20214:15PMGlobeNewswire Inc.OpGen Reports Second Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:OPGNOpGen Inc
08/09/20215:19PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:OPGNOpGen Inc
08/05/20219:42AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OPGNOpGen Inc
08/05/20219:40AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
 Showing the most relevant articles for your search:NASDAQ:OPGN